Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
News|Articles|January 31, 2025
5 Key Takeaways From RFK Jr’s Confirmation Hearings
Author(s)Pearl Steinzor
This week, Robert F. Kennedy Jr sat before the Senate for 2 separate hearings, to decide the fate of his confirmation as secretary of HHS.
Advertisement
Advertisement
This week, Robert F. Kennedy Jr sat before the Senate for 2 separate hearings, to decide the fate of his confirmation as secretary of HHS. If confirmed, he would lead a federal agency responsible for overseeing the health care of millions of Americans, regulating access to drugs and vaccines, and managing disease outbreaks.
Related to this article
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
Experts explain why access to specialty cancer care, open dialogue, and patient education are essential to building trust and making informed treatment decisions.
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
Advertisement
Advertisement